Abstract: This invention relates to the development of products that are alternatives to antibiotics with medically important human therapeutic uses for livestock meat and protein production efficiency. These products will be used to replace antibiotics used to rapidly increase lean muscle mass with specific feed regimens. The present invention is for the identification of non-human antibiotic products to be used with different feed regimens for livestock growth and meat promotion that include prebiotic supplements and keystone species probiotics that produce the desired growth promotion phenotypic effects. The present invention includes the identification of enterotypes that can be used as targets for recapitulation by compounds that are screened to produce the desired phenotype.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.

Abstract: This invention relates to the development of prebiotic and probiotic products that treat obesity and overweight conditions and allow people with these tendencies to covert food to lean muscle mass rather than fat.

Abstract: This invention relates to the development of products that are alternatives to antibiotics with medically important human therapeutic uses for livestock meat and protein production efficiency. These products will be used to replace antibiotics used to rapidly increase lean muscle mass with specific feed regimens. The present invention is for the identification of non-human antibiotic products to be used with different feed regimens for livestock growth and meat promotion that include prebiotic supplements and keystone species probiotics that produce the desired growth promotion phenotypic effects. The present invention includes the identification of enterotypes that can be used as targets for recapitulation by compounds that are screened to produce the desired phenotype.

Abstract: This invention relates to the medical use of pathogen associated molecular pattern (PAMP) displaying immunostimulatory microbial immuno-adjuvants [MIAs], as therapeutics when used in combination with check point inhibitors to treat various types of cancer and to methods of treatment which involve treating a subject with these compounds and compound mixtures and process methods for identifying and optimally composing them for their therapeutic use in cancer treatment. It also relates to the use of inhibitors of these PAMP displaying immunostimulatory microbial immuno-adjuvants [MIAs], as therapeutics when used to treat inflammatory bowel disease (IBD) including Crohn's Disease and ulcerative colitis and irritable bowel syndrome (IBS) and process methods for identifying and optimally composing them for their therapeutic use in IBD and IBS.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives, and in particular, beta lactam antibiotics combined with beta lactamase inhibitors, like co-amoxiclay. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives and their use with bio-threat pathogens that utilize a mechanism of tolerance or resistance by facultatively switching from aerobic to anaerobic confirmations and by switching back and forth from planktonic to biofilm forms.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.

Abstract: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.

Abstract: A method for effecting a near field communication, including the steps of positioning a first device at a close proximity to a second device, wherein the close proximity is suitable for the near field communication; and sending a first effectively carrierless signal from the first device to the second device.

Abstract: A device is described which enables users to interact with software running on the device through gestures made in an area adjacent to the device. In an embodiment, a portable computing device has proximity sensors arranged on an area of its surface which is not a display, such as on the sides of the device. These proximity sensors define an area of interaction adjacent to the device. User gestures in this area of interaction are detected by creating sensing images from data received from each of the sensors and then analyzing sequences of these images to detect gestures. The detected gestures may be mapped to particular inputs to a software program running on the device and therefore a user can control the operation of the program through gestures.

Abstract: Disclosed are antennas for printed circuit boards (PCB) including a printed circuit board having antenna conductors, ground plane, an insulating substrate and a feed structure. The antenna is at least partially formed by an array of two similarly sized and shaped antenna elements. Each antenna element is oriented substantially orthogonal to the other and similarly positioned relative to the ground plane. The two antenna elements are coupled to the feed structure and are connectable to a transceiver such that when the two like antenna elements are fed differentially the far fields of each antenna are substantially similar and substantially orthogonal to each other so as to provide substantial omni-directionality.

Abstract: A device is described which enables users to interact with software running on the device through gestures made in an area adjacent to the device. In an embodiment, a portable computing device has proximity sensors arranged on an area of its surface which is not a display, such as on the sides of the device. These proximity sensors define an area of interaction adjacent to the device. User gestures in this area of interaction are detected by creating sensing images from data received from each of the sensors and then analyzing sequences of these images to detect gestures. The detected gestures may be mapped to particular inputs to a software program running on the device and therefore a user can control the operation of the program through gestures.

Abstract: A method for effecting a near field communication, including the steps of positioning a first device at a close proximity to a second device, wherein the close proximity is suitable for the near field communication; and sending a first effectively carrierless signal from the first device to the second device.

Abstract: A device is described which enables users to interact with software running on the device through gestures made in an area adjacent to the device. In an embodiment, a portable computing device has proximity sensors arranged on an area of its surface which is not a display, such as on the sides of the device. These proximity sensors define an area of interaction adjacent to the device. User gestures in this area of interaction are detected by creating sensing images from data received from each of the sensors and then analyzing sequences of these images to detect gestures. The detected gestures may be mapped to particular inputs to a software program running on the device and therefore a user can control the operation of the program through gestures.

Abstract: Methods and apparatus for uniquely identifying wireless devices in close physical proximity are described. When two wireless devices are brought into close proximity, one of the devices displays an optical indicator, such as a light pattern. This device then sends messages to other devices which are within wireless range to cause them to use any light sensor to detect a signal. In an embodiment, the light sensor is a camera and the detected signal is an image captured by the camera. Each device then sends data identifying what was detected back to the device displaying the pattern. By analyzing this data, the first device can determine which other device detected the indicator that it displayed and therefore determine that this device is within close physical proximity. In an example, the first device is an interactive surface arranged to identify the wireless addresses of devices which are placed on the surface.

Abstract: A method is disclosed of producing an RFID tag assembly including an associated antenna and attachment means suitable for attaching the tag assembly to a material. The material may be flexible such as fabric or relatively rigid such as cardboard. The method includes forming the associated antenna and the attachment means as a unitary conductive frame. An RFID tag assembly produced by the method is also disclosed.

Abstract: A combined EAS/RFID tag including an EAS circuit and a first RFID circuit is disclosed. The EAS circuit has at least one capacitor and the RFID circuit has a main antenna wherein at least a part of the capacitor of the EAS circuit provides at least a part of the main antenna of the RFID circuit. The EAS circuit may include two capacitors and each capacitor may include first and second plates on first and second sides of a substrate wherein one plate of each capacitor forms part of the main antenna of the RFID circuit.

Abstract: Methods and apparatus for uniquely identifying wireless devices in close physical proximity are described. When two wireless devices are brought into close proximity, one of the devices displays an optical indicator, such as a light pattern. This device then sends messages to other devices which are within wireless range to cause them to use any light sensor to detect a signal. In an embodiment, the light sensor is a camera and the detected signal is an image captured by the camera. Each device then sends data identifying what was detected back to the device displaying the pattern. By analyzing this data, the first device can determine which other device detected the indicator that it displayed and therefore determine that this device is within close physical proximity. In an example, the first device is an interactive surface arranged to identify the wireless addresses of devices which are placed on the surface.